Scarica l'app Stockscreener
36.40
0.19%
-0.07
Dopo l'orario di chiusura:
36.00
-0.40
-1.10%
Newamsterdam Pharma Company Nv Borsa (NAMS) Ultime notizie
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock a top pick in earnings season - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock benefit from commodity pricesPortfolio Return Summary & Short-Term Trading Alerts - newser.com
NewAmsterdam Pharma Co. NV Hits New 52-Week High of USD 41.39 - Markets Mojo
Published on: 2025-10-15 11:31:06 - newser.com
Tools to assess NewAmsterdam Pharma Company N.V.’s risk profileQuarterly Earnings Report & Long Hold Capital Preservation Plans - newser.com
Newamsterdam Pharma stock hits all-time high at 39.76 USD By Investing.com - Investing.com South Africa
Newamsterdam Pharma stock hits all-time high at 39.76 USD - Investing.com
Can NewAmsterdam Pharma Company N.V. stock resist sector downturnsJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
Is NewAmsterdam Pharma Company N.V. stock a good choice for value investorsTrade Exit Summary & Verified Short-Term Plans - newser.com
NewAmsterdam Pharma Company N.V. recovery potential after sell offJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com
Advanced analytics toolkit walkthrough for NewAmsterdam Pharma Company N.V. Equity Warrant2025 Top Gainers & AI Enhanced Execution Alerts - newser.com
Can technical indicators confirm NewAmsterdam Pharma Company N.V. Equity Warrant’s reversalJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
NewAmsterdam Pharma Hits New 52-Week High of $39.76, Up 88.77% - Markets Mojo
Using fundamentals and technicals on NewAmsterdam Pharma Company N.V. Equity Warrant2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - newser.com
Caristo Chosen by Leading Pharma Company as Worldwide Imaging Core Lab to Measure Coronary Plaque and Inflammation (2025-10-14) - Seeking Alpha
How to track smart money flows in NewAmsterdam Pharma Company N.V. Equity WarrantPortfolio Performance Summary & Community Driven Trade Alerts - newser.com
Real time alert setup for NewAmsterdam Pharma Company N.V. Equity Warrant performanceJuly 2025 Setups & Step-by-Step Trade Execution Guides - newser.com
Can you recover from losses in NewAmsterdam Pharma Company N.V.Quarterly Risk Review & Weekly Market Pulse Alerts - newser.com
Why NewAmsterdam Pharma Company N.V. Equity Warrant stock attracts global investorsJuly 2025 Short Interest & Weekly Stock Performance Updates - newser.com
Technical analysis overview for NewAmsterdam Pharma Company N.V. Equity Warrant stockMarket Performance Summary & Accurate Trade Setup Notifications - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant forming a bottoming baseEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com
Is it too late to sell NewAmsterdam Pharma Company N.V. Equity WarrantEarnings Beat & High Conviction Buy Zone Picks - newser.com
Will earnings trigger a reversal in NewAmsterdam Pharma Company N.V.Recession Risk & Fast Exit/Entry Strategy Plans - newser.com
Published on: 2025-10-13 07:22:45 - newser.com
Published on: 2025-10-12 22:17:07 - newser.com
What Insider Transactions Reveal About Hindusthan Urban Infrastructure Limiteds OutlookReal-Time Stock Alerts & Free Powerful Profit Generation - earlytimes.in
NewAmsterdam Pharma (NASDAQ:NAMS) Hits New 12-Month HighHere's Why - MarketBeat
NewAmsterdam Pharma (NAMS) Stock Soars on Cholesterol Drug Breakthrough – What Investors Should Know - ts2.tech
NAMS Stock Surge: What Lies Ahead? - timothysykes.com
NewAmsterdam Pharma (NASDAQ:NAMS) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Why NewAmsterdam Pharma (NAMS) Is Up 7.5% After Late-Stage Obicetrapib Trial Optimism - Yahoo Finance
NewAmsterdam Pharma Company N.V. Equity Warrant stock trend forecastMarket Sentiment Review & Weekly High Conviction Trade Ideas - newser.com
Exit strategy if you’re trapped in NewAmsterdam Pharma Company N.V. Equity WarrantEarnings Beat & Reliable Price Breakout Signals - newser.com
Is this a good reentry point in NewAmsterdam Pharma Company N.V.Weekly Stock Analysis & Smart Investment Allocation Insights - newser.com
Custom watchlist performance reports with NewAmsterdam Pharma Company N.V.Weekly Market Report & Daily Technical Forecast Reports - newser.com
NewAmsterdam Pharma Company N.V. stock momentum explainedTrend Reversal & AI Enhanced Execution Alerts - newser.com
Topper, director at NewAmsterdam Pharma, buys $31,487 in shares By Investing.com - Investing.com Nigeria
Knights of Columbus Asset Advisors LLC Invests $595,000 in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma Hits New 52-Week High of $34.62 - Markets Mojo
NewAmsterdam Pharma Company N.V. (NAMS) Soars 5.9%: Is Further Upside Left in the Stock? - Nasdaq
NewAmsterdam Pharma (NAMS) Stock Analysis: Uncovering a Promising 25% Upside in Biotechnology - DirectorsTalk Interviews
Newamsterdam Pharma stock hits 52-week high at 31.96 USD By Investing.com - Investing.com Canada
NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Up 8.8%Here's Why - MarketBeat
NewAmsterdam Pharma Co. Hits New 52-Week High of USD 31.81 - Markets Mojo
Is NewAmsterdam Pharma Company NV a good long term investmentRSI Overbought/Oversold & Exceptional Profit Trading - earlytimes.in
Newamsterdam Pharma stock hits 52-week high at 31.96 USD - Investing.com
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):